Rhizen Pharmaceuticals
Phase 2Developing next generation medicines that will lead the fight against cancer & inflammation
Founded
2008
Focus
Small Molecules
About
Developing next generation medicines that will lead the fight against cancer & inflammation
Funding History
3Total raised: $47M
Grant$2MSwiss Innovation AgencyJun 15, 2020
Series B$30MUndisclosedJun 15, 2018
Series A$15MUndisclosedJun 15, 2016
Company Info
TypePrivate
Founded2008
LocationBasel, Switzerland
StagePhase 2
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile